Doxorubicin Active Not Recruiting Phase 3 Trials for Recurrent Ovarian Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01802749Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer